Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2009, Article ID 934698, 11 pages
http://dx.doi.org/10.1155/2009/934698
Research Article

Cost-Effectiveness of Universal Prophylaxis in Pregnancy with Prior Group B Streptococci Colonization

Department of Obstetrics, Gynecology and Reproductive Sciences, Kelsey Research Foundation, University of Texas Medical School, Houston, TX 77007, USA

Received 10 May 2009; Revised 7 September 2009; Accepted 8 October 2009

Academic Editor: Austin Ugwumadu

Copyright © 2009 Mark A. Turrentine et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Schrag, R. Gorwitz, K. Fultz-Butts, and A. Schuchat, “Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC,” Morbidity and Mortality Weekly Report, vol. 51, no. RR-11, pp. 1–22, 2002. View at Google Scholar · View at Scopus
  2. American College of Obstetricians and Gynecologists, “ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns,” Obstetrics & Gynecology, vol. 100, no. 6, pp. 1405–1412, 2002. View at Google Scholar
  3. P.-J. Cheng, H.-Y. Chueh, C.-M. Liu, J.-J. Hsu, T.-T. Hsieh, and Y.-K. Soong, “Risk factors for recurrence of group B streptococcus colonization in a subsequent pregnancy,” Obstetrics & Gynecology, vol. 111, no. 3, pp. 704–709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Turrentine and M. M. Ramirez, “Recurrence of group B streptococci colonization in subsequent pregnancy,” Obstetrics & Gynecology, vol. 112, no. 2, part 1, pp. 259–264, 2008. View at Google Scholar · View at Scopus
  5. R. K. Edwards, P. Clark, and P. Duff, “Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates,” Obstetrics & Gynecology, vol. 100, no. 3, pp. 540–544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. R. L. Davis, M. B. Hasselquist, V. Cardenas et al., “Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large west coast health maintenance organization,” American Journal of Obstetrics and Gynecology, vol. 184, no. 4, pp. 603–610, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Ottolini, K. Lundgren, L. J. Mirkinson, S. Cason, and M. G. Ottolini, “Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn,” Pediatric Infectious Disease Journal, vol. 22, no. 5, pp. 430–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Rouse, R. L. Goldenberg, S. P. Cliver, G. R. Cutter, S. T. Mennemeyer, and C. A. Fargason Jr., “Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis,” Obstetrics & Gynecology, vol. 83, no. 4, pp. 483–494, 1994. View at Google Scholar · View at Scopus
  9. O. Idsoe, T. Guthe, R. R. Willcox, and A. L. de Weck, “Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock,” Bulletin of the World Health Organization, vol. 38, no. 2, pp. 159–188, 1968. View at Google Scholar · View at Scopus
  10. J. B. Kerr, “Penicillin allergy: a study of incidence as reported by patients,” British Journal of Clinical Practice, vol. 48, no. 1, pp. 5–7, 1994. View at Google Scholar · View at Scopus
  11. K. A. Matteson, S. P. Lievense, B. Catanzaro, and M. G. Phipps, “Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy,” Obstetrics & Gynecology, vol. 111, no. 2, part 1, pp. 356–364, 2008. View at Google Scholar · View at Scopus
  12. G. B. Merenstein, W. A. Todd, G. Brown, C. C. Yost, and T. Luzier, “Group B β-hemolytic streptococcus: randomized controlled treatment study at term,” Obstetrics & Gynecology, vol. 55, no. 3, pp. 315–318, 1980. View at Google Scholar · View at Scopus
  13. J. G. Allardice, T. F. Baskett, M. M. K. Seshia, N. Bowman, and R. Malazdrewicz, “Perinatal group B streptococcal colonization and infection,” American Journal of Obstetrics & Gynecology, vol. 412, no. 6, pp. 617–620, 1982. View at Google Scholar
  14. W. J. Morales, D. V. Lim, and A. F. Walsh, “Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis,” American Journal of Obstetrics and Gynecology, vol. 155, no. 5, pp. 979–983, 1986. View at Google Scholar · View at Scopus
  15. N. Tuppurainen and M. Hallman, “Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients,” Obstetrics & Gynecology, vol. 73, no. 4, pp. 583–587, 1989. View at Google Scholar · View at Scopus
  16. K. M. Boyer and S. P. Gotoff, “Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis,” The New England Journal of Medicine, vol. 314, no. 26, pp. 1665–1669, 1986. View at Google Scholar · View at Scopus
  17. R. Mattoras, A. Garcia-Perea, F. Omenaca, M. Diez-Enciso, R. Madero, and J. A. Usandizaga, “Intrapartum chemoprophylaxis of early-onset group B streptococcal disease,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 40, no. 1, pp. 57–62, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. W. E. Benitz, J. B. Gould, and M. L. Druzin, “Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis,” Pediatrics, vol. 103, no. 6, article e76, pp. 1–12, 1999. View at Google Scholar · View at Scopus
  19. S. J. Schrag, E. R. Zell, R. Lynfield et al., “A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates,” The New England Journal of Medicine, vol. 347, no. 4, pp. 233–239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. B. Johannes, N. Ziyadeh, J. D. Seeger, E. Tucker, C. Reiter, and G. Faich, “Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation,” Drug Safety, vol. 30, no. 8, pp. 705–713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Phillips, M. Louie, S. R. Knowles, A. E. Simor, and P. I. Oh, “Cost-effectiveness analysis of six strategies for cardiovascular surgery prophylaxis in patients labeled penicillin allergic,” American Journal of Health-System Pharmacy, vol. 57, no. 4, pp. 339–345, 2000. View at Google Scholar · View at Scopus
  22. C. A. Fargason, M. Peralta-Carcelen, D. J. Rouse, G. R. Cutter, and R. L. Goldenberg, “The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease,” Obstetrics & Gynecology, vol. 90, no. 3, pp. 347–352, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Balter, E. R. Zell, K. L. O'Brien et al., “Impact of intrapartum antibiotics on the care and evaluation of the neonate,” Pediatric Infectious Disease Journal, vol. 22, no. 10, pp. 853–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Siegel, M. C. Weinstein, L. B. Russell, and M. R. Gold, “Recommendations for reporting cost-effectiveness analyses,” Journal of the American Medical Association, vol. 276, no. 16, pp. 1339–1341, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Harris, M. Helfand, S. H. Woolf et al., “Current methods of the U.S. preventive services task force: a review of the process,” American Journal of Preventive Medicine, vol. 20, no. 3, supplement 1, pp. 21–35, 2001. View at Google Scholar · View at Scopus
  26. B. Tejada-Vera and P. D. Sutton, “Births, marriages, divorces, and deaths: provisional data for 2007,” National Vital Statistics Reports, vol. 56, no. 21, pp. 1–6, 2008. View at Google Scholar
  27. B. E. Hamilton, J. A. Martin, and S. J. Ventura, “Births: preliminary data for 2006,” National Vital Statistics Reports, vol. 56, no. 7, pp. 1–18, 2007. View at Google Scholar · View at Scopus
  28. J. A. Martin, B. E. Hamilton, P. D. Sutton, S. J. Ventura, F. Menacker, and S. Kirmeyer, “Births: final data for 2004,” National Vital Statistics Reports, vol. 55, no. 1, pp. 1–101, 2006. View at Google Scholar · View at Scopus
  29. M. D. Yow, L. J. Leeds, P. K. Thompson, E. O. Mason Jr., D. J. Clark, and C. W. Beachler, “The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies,” American Journal of Obstetrics and Gynecology, vol. 137, no. 1, pp. 34–38, 1980. View at Google Scholar · View at Scopus
  30. R. Leone, A. Conforti, M. Venegoni et al., “Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database,” Drug Safety, vol. 28, no. 6, pp. 547–556, 2005. View at Google Scholar
  31. “Consumer Price Index Inflation Calculator,” Bureau of Labor Statistics, Washington, DC, USA http://www.bls.gov/cpi/.
  32. M. K. Yancey and P. Duff, “An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection,” Obstetrics & Gynecology, vol. 83, no. 3, pp. 367–371, 1994. View at Google Scholar · View at Scopus
  33. J. C. Mohle-Boetani, A. Schuchat, B. D. Plikaytis, J. D. Smith, and C. V. Broome, “Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic analysis,” Journal of the American Medical Association, vol. 270, no. 12, pp. 1442–1448, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. Centers for Medicare and Medicaid Services, “Fee schedule—general information 2008,” http://www.cms.hhs.gov/FeeScheduleGenInfo/.
  35. M. B. Greenberg, Y. W. Cheng, L. M. Hopkins, N. E. Stotland, A. S. Bryant, and A. B. Caughey, “Are there ethnic differences in the length of labor?” American Journal of Obstetrics and Gynecology, vol. 195, no. 3, pp. 743–748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Amerisource Bergen Drug Corporation, “The blue book wholesale price average,” http://www.amerisourcebergen.com/cp/1/.
  37. D. M. Gencarelli, “One pill, many prices: variation in prescription drug prices in selected government programs,” National Health Policy Forum, no. 807, pp. 1–20, 2005. View at Google Scholar · View at Scopus
  38. J. C. Mohle-Boetani, T. A. Lieu, G. T. Ray, and G. Escobar, “Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics,” Pediatrics, vol. 103, no. 4, pp. 703–710, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. K. R. Blank, M. A. Cascardi, and G. D. Kao, “The utility of serial complete blood count monitoring in patients receiving radiation therapy for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 44, no. 2, pp. 317–321, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. P. L. McCarthy, G. W. Grundy, S. Z. Spiesel, and T. F. Dolan Jr., “Bacteremia in children: an outpatient clinical review,” Pediatrics, vol. 57, no. 6, pp. 861–868, 1976. View at Google Scholar · View at Scopus
  41. T. A. Lieu, J. C. Mohle-Boetani, G. T. Ray, L. M. Ackerson, and D. L. Walton, “Neonatal group B streptococcal infection in a managed care population,” Obstetrics & Gynecology, vol. 92, no. 1, pp. 21–27, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. M. E. Van den Akker-van Marle, M. E. B. Rijnders, P. van Dommelen et al., “Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease,” BJOG, vol. 112, no. 6, pp. 820–826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. T. S. Glasgow, M. Speakman, S. Firth, B. James, C. L. Byington, and P. C. Young, “Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers,” Paediatric and Perinatal Epidemiology, vol. 21, no. 4, pp. 338–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. “Newborns' and mothers' health protection act of 1996,” 42 USC 1185 601 (Pub L No. 104-204).
  45. L. J. Kozak, C. J. DeFrances, and M. J. Hall, “National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data,” Vital and Health Statistics, vol. 13, no. 162, pp. 1–218, 2006. View at Google Scholar
  46. National center for health statistics, Health, United States, 2007 with Chartbook on Trends in the Health of Americans, National Center for Health Statistics, Hyattsville, Md, USA, 2007.
  47. A. Reingold, K. Gershman, S. Petit et al., “Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003–2005,” Morbidity and Mortality Weekly Report, vol. 56, no. 28, pp. 701–705, 2007. View at Google Scholar · View at Scopus
  48. M. C. Weinstein, J. E. Siegel, M. R. Gold, M. S. Kamlet, and L. B. Russell, “Recommendations of the panel on cost-effectiveness in health and medicine,” Journal of the American Medical Association, vol. 276, no. 15, pp. 1253–1258, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. J. P. Watt, A. Schuchat, K. Erickson, J. E. Honig, R. Gibbs, and J. Schulkin, “Group B streptococcal disease prevention practices of obstetrician-gynecologists,” Obstetrics & Gynecology, vol. 98, no. 1, pp. 7–13, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Sheikh, “Intrapartum anaphylaxis to penicillin in a woman with rheumatoid arthritis who had no prior penicillin allergy,” Annals of Allergy, Asthma and Immunology, vol. 99, no. 3, pp. 287–289, 2007. View at Google Scholar · View at Scopus
  51. R. Spaetgens, K. DeBella, D. Ma, S. Robertson, M. Mucenski, and H. D. Davies, “Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens,” Obstetrics & Gynecology, vol. 100, no. 3, pp. 525–533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. R. K. Edwards, P. Clark, C. L. Sistrom, and P. Duff, “Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens,” Obstetrics & Gynecology, vol. 100, no. 3, pp. 534–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. J. Schrag, J. L. Hadler, K. E. Arnold, P. Martell-Cleary, A. Reingold, and A. Schuchat, “Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use,” Pediatrics, vol. 118, no. 2, pp. 570–576, 2006. View at Publisher · View at Google Scholar · View at Scopus